Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Moderate to Severe Hidradenitis Suppurativa
BulgariaStudy of Hydroxychloroquine Safety and Effectiveness in Patients with Early Systemic Sclerosis
ItalyStudy on the Effectiveness and Safety of 0.1% Mometasone Furoate Emulsion and Ecural Cream for Adults with Plaque Psoriasis
PolandStudy of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery
GermanyStudy on Prednisone and Antihistamine for Treating Acute Urticaria in Adults at the Emergency Department
FranceStudy on the Effects of Barzolvolimab for Patients with Prurigo Nodularis
CroatiaStudy Comparing Methylprednisolone Aceponate Ointment and a Drug Combination for Patients with Mild to Moderate Atopic Dermatitis
GermanyStudy of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies
BulgariaStudy of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)
BulgariaStudy on the Safety and Effects of Sebetralstat for Children Aged 2-11 with Hereditary Angioedema Type I or II
FranceStudy on the Effectiveness of Pembrolizumab and Ipilimumab in Melanoma Patients with Brain Metastases Requiring Steroid Treatment
DenmarkStudy on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines
FranceThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
